The Amazon, Facebook & YouTube Video Wars Are Heating up, Explains New TrueShip Guide

SCOTTSDALE, AZ —(Marketwired – May 19, 2016) – TrueShip ( — the leading provider of ecommerce shipping software (ReadyShipper) and automated returns management solutions (ReadyReturns) — has just released a new guide that covers the video wars that are taking place among mega–giants, Amazon, Facebook and YouTube.

With YouTube being the king of the video mountain for as long as anyone can recall, another contender to the throne has been a long time in coming. As Amazon steps into the ring and Facebook ups its ante, the thick of battle is just commencing.

TrueShip's new guide helps you better understand how these video wars will shape up, complete with detailed charts, in–depth statistics and a palpable comparison and contrast of these services, their reach and their social saturation. 

“Today more than ever before, marketers have the most channels to choose from when looking for video dissemination,” commented Michael Lazar, Director of Online Marketing at TrueShip. “Our new guide helps you better understand how effective these various media channels are, and why they are suddenly embroiled in a battle for the ages.”

Read the new guide here:–wars–amazon–facebook–youtube–empires–collide.

Visit TrueShip online to learn more at: Or call toll–free at: (877) 818–7447.

About TrueShip

#ShipSmarter — TrueShip is the original architect of multi–carrier ecommerce shipping software. ReadyShipper shipping software integrates into the most widely used shopping carts and online marketplaces. It is an easy–to–use order fulfillment solution designed to save e–retailers time and money.

Start a 14–day trial of ReadyShipper shipping software by visiting:

About ReadyReturns

#ReturnsHappen — ReadyReturns is a customer–facing, plug–and–play, self–service online product returns software solution. It integrates into virtually any website without any programming. ReadyReturns lets customers make returns from a website by filling out a simple form and printing the return shipping label. E–retailers set the rules of the returns, including things like return shipping and restocking fees.

Start a 30–day trial of ReadyReturns by visiting:–retail–returns.

Advanced Proteome Closes Private Placement

VANCOUVER, BC—(Marketwired – May 19, 2016) –


Advanced Proteome Therapeutics Corporation (“APC” or the “Company”) (TSX VENTURE: APC) (FRANKFURT: 0E8) is pleased to announce that it has closed the non–brokered private placement financing (“Private Placement”) announced April 18, 2016 by the issuance of an aggregate of 5,703,000 units (“Units”) at a purchase price of $0.05 per Unit for gross proceeds of $285,150. Each Unit consists of one common share in the capital of the Company and one–half of a transferable share purchase warrant. Each whole warrant entitles the holder thereof to purchase one additional common share in the capital of the Company on or before May 19, 2017, at a purchase price of $0.10 per share.

In connection with the Private Placement, the Company paid finder's fees to Haywood Securities Inc. consisting of (i) $18,980 in cash; and (ii) issuance of 379,600 non–transferable warrants, each warrant entitling Haywood to acquire one common share in the capital of the Company on or before May 19, 2017 at a purchase price of $0.10 per share.

Two directors of the Company subscribed for an aggregate of 958,000 Units.

All securities issued by the Company pursuant to the Private Placement are subject to a hold period of four months and one day and cannot be resold until September 20, 2016.

Net proceeds from the Private Placement will be allocated for general working capital and to advance the Company's capabilities in the area of site specific labeling of therapeutic antibodies, with the goal of producing improved versions of antibody–drug conjugates, to bolster ongoing serious negotiations for partnering deals as well as other business development activities.

The Private Placement is subject to final approval by the TSX Venture Exchange.

About APC

Advanced Proteome Therapeutics Corporation (APC) is advancing a Site–Specific Protein Modification technology platform to enable the development of superior protein therapeutics. Using this technology, the Company has generated numerous and diverse modifications of Annexin V with superior binding and stability properties and are amenable to further labeling and conjugation for use in therapeutic applications. APC is now applying its technologies to achieve the site–specific labeling of therapeutic antibodies and provide the next generation of antibody–drug conjugates.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release. The forward–looking statements contained in this news release involve risks and uncertainties, and are subject to change based on various important factors including timely development and acceptance of new products, gaining product approval, successful entry into new markets, changes in financing conditions, and changes in FDA regulations.